Assenagon Asset Management S.A. Adverum Biotechnologies, Inc. Transaction History

Assenagon Asset Management S.A.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	SELL	$0.54 - $10.3 $54,594 - $1.04 Million	-101,100 Reduced 10.74%	840,651 $487,000
Q2 2022 Jul 27, 2022	SELL	$0.81 - $1.34 $41,292 - $68,310	-50,978 Reduced 5.14%	941,751 $1.13 Million
Q1 2022 Apr 25, 2022	BUY	$1.23 - $1.95 $680,380 - $1.08 Million	553,155 Added 125.84%	992,729 $1.3 Million
Q4 2021 Feb 01, 2022	SELL	$1.74 - $2.4 $1.79 Million - $2.47 Million	-1,027,233 Reduced 70.03%	439,574 $774,000
Q3 2021 Oct 19, 2021	SELL	$2.08 - $3.6 $332,573 - $575,607	-159,891 Reduced 9.83%	1,466,807 $3.18 Million
Q2 2021 Jul 15, 2021	BUY	$3.36 - $10.56 $5.47 Million - $17.2 Million	1,626,698 New	1,626,698 $5.69 Million
Q1 2021 Apr 26, 2021	SELL	$9.26 - $14.36 $205,553 - $318,763	-22,198 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$9.84 - $14.26 $2.47 Million - $3.58 Million	-251,003 Reduced 91.87%	22,198 $240,000
Q3 2020 Oct 07, 2020	SELL	$10.3 - $21.64 $484,244 - $1.02 Million	-47,014 Reduced 14.68%	273,201 $2.81 Million
Q2 2020 Jul 21, 2020	BUY	$8.53 - $25.64 $2.73 Million - $8.21 Million	320,215 New	320,215 $6.69 Million
Q1 2019 Apr 26, 2019	SELL	$3.03 - $6.02 $304,690 - $605,359	-100,558 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$2.87 - $5.92 $288,601 - $595,303	100,558 New	100,558 $317,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.